The visual evoked potential (VEP) generated by the amblyopic visual system demonstrates reduced amplitude, prolonged latency, and increased variation in response timing (phase-misalignment). This study examined VEPs before and after occlusion therapy (OT) and whether phase-misalignment can account for the amblyopic VEP deficits. VEPs were recorded to 0.5-4 cycles/degree gratings in 10 amblyopic children (2-6 years age) before and after OT. Phase-misalignment was measured by Fourier analysis across a limited bandwidth. Signal-to-noise ratios (SNRs) were estimated from amplitude and phase synchrony in the Fourier domain. Responses were compared to VEPs corrected for phase-misalignment (individual epochs shifted in time to correct for the misalignment). Before OT, amblyopic eyes (AE) had significantly more phase-misalignment, latency prolongation, and lower SNR relative to the fellow eye. Phase-misalignment contributed significantly to low SNR but less so to latency delay in the AE. After OT, phase-alignment improved, SNR improved and latency shortened in the AE. Raw averaged waveforms from the AE improved after OT, primarily at higher spatial frequencies. Correcting for phase-misalignment in the AE sharpened VEP peak responses primarily at low spatial frequencies, but could not account for VEP waveform improvements in the AE after OT at higher spatial frequencies. In summary, VEP abnormalities from the AE are associated with phase-misalignment and reduced SNR possibly related to desynchronization of neuronal activity. The effect of OT on VEP responses is greater than that accounted for by phase-misalignment and SNR alone.
Introduction
Unilateral amblyopia is typically defined as reduced visual acuity in one eye due to anisometropia, strabismus, or visual deprivation resulting from ptosis or media opacity. For each of these disorders a suboptimal retinal image in one eye, interocular disparity of visual inputs, or both limit the postnatal visual development of one eye resulting in decreased visual acuity. Additional visual deficits include reduced contrast sensitivity, reduced Vernier acuity, temporal instability, motion, and global motion deficits, and abnormal contour interactions (Altmann & Singer, 1986; Giaschi, Regan, Kraft, & Hong, 1992; Hess & Holliday, 1992; Ho et al., 2005; Levi & Klein, 1983; Levi & Klein, 1985; Simmers, Ledgeway, Hess, & McGraw, 2003; Sireteanu, Lagreze, & Constantinescu, 1993) . Treatment for amblyopia includes detection and correction of the underlying ocular disorder. To recapture optimal vision in the amblyopic eye, monocular occlusion therapy, or pharmacological or optical blurring, of the fellow eye is performed during the critical period of visual development (Epelbaum, Milleret, Buisseret, & Dufier, 1993; Flynn et al., 1999; Vaegan, 1979) .
Animal models using induced anisometropia or strabismus have provided important insights into the cortical mechanisms underlying amblyopic visual loss (Crewther & Crewther, 1990; Hendrickson et al., 1987; Kiorpes, Kiper, O'Keefe, Cavanaugh, & Movshon, 1998; Movshon et al., 1987; Roelfsema et al., 1994; Singer, von Grünau, & Rauschecker, 1980) . Recordings in visual striate cortex (V1) show a change from predominately binocularly encoded cells to approximately the same number of neurons being driven by the amblyopic eye as the fellow eye. However, neurons driven by the amblyopic eye can show similar spatial response properties and similar firing rates as the fellow eye despite behavioral measures showing reduced spatial resolution in the amblyopic eye (Bi et al., 2011; Kiorpes, Kiper, O'Keefe, Cavanaugh, & Movshon, 1998; Kiorpes & Movshon, 2003) . This finding suggests that deficits in V1 neurons are insufficient to account for behavioral vision loss at high spatial frequencies in the primate model. An emerging view is that integration of cortical areas downstream from V1 play a significant role in the visual defects imposed by early strabismus or anisometropia (Bi et al., 2011; Chino, Bi, & Zhang, 2003; El-Shamayleh, Kiorpes, Kohn, & Movshon, 2010; Imamura et al., 1997; Kiorpes & Movshon, 2003; Kiorpes et al., 1998; Li, Mullen, Thompson, & Hess, 2011; Singer et al., 1980) .
The visual evoked potential (VEP) provides an objective way to assess visual cortex in amblyopic children during the critical period (Arden, Barnard, & Mushin, 1974; Friendly, Weiss, Barnet, Saumweber, & Walker, 1986; Henc-Petrinovic, Deban, Gabric, & Petrinovic, 1993; Kubova, Kuba, Juran, & Blakemore, 1996; Levi & Manny, 1982; Lombroso, Duffy, & Robb, 1969; Sokol, 1983; Sokol & Bloom, 1973; Spekreijse, Khoe, & van der Tweel, 1972; Weiss & Kelly, 2004; Wright, Ary, Shors, & Eriksen, 1986) . The VEP response is thought to be dominated by population summation of excitatory post-synaptic potentials from pyramidal cells in striate and extrastriate visual cortex (Mitzdorf & Singer, 1978; Nunez & Srinivasan, 2006) . The VEP peak near 60 ms reflects initial activation of visual striate cortex whereas the VEP peak near 100 ms reflect combined activity of visual striate and extrastriate cortical areas (Clark, Fan, & Hillyard, 1995; Di Russo, Martinez, Sereno, Pitzalis, & Hillyard, 2002; Di Russo et al., 2005; Foxe & Simpson, 2002; Maier, Dagnelie, Spekreijse, & van Dijk, 1987; Nakamura, Kakigi, Okusa, Hoshiyama, & Watanabe, 2000; Ossenblok, Reits, & Spekreijse, 1992; Schroeder, Mehta, & Givre, 1998) . Thus the VEP is ideal for measuring neuronal integration across multiple visual cortex areas in children during therapy. The VEP from the amblyopic eye consistently shows reduced amplitudes, altered waveforms, and prolonged latency at spatial frequencies below behavioral acuity thresholds. Although the amblyopic eye shows a small latency delay (10-20 ms), this timing is potentially important for integration between V1 and extrastriate cortex (Di Russo, Martinez, Sereno, Pitzalis, & Hillyard, 2002; Foxe & Simpson, 2002; Schroeder et al., 1998) . After occlusion therapy, the amblyopic eye generates a VEP with increased amplitude, shorter latency, and sharper timing of peaks (Arden & Barnard, 1979; Arden, Barnard, & Mushin, 1974; Friendly et al., 1986; Furuskog, Persson, & Wanger, 1987; Henc-Petrinovic et al., 1993; Kubova, Kuba, Juran, & Blakemore, 1996; Odom, Hoyt, & Marg, 1981; Wilcox & Sokol, 1980; Weiss & Kelly, 2004) . In comparison, after termination of therapy the treated fellow eye shows mild changes in amplitude reduction, latency prolongation, and waveform broadening that can persist for more than 3 months. The VEP changes in latency must be post-retinal since the pattern-electroretinogram shows no latency difference between the amblyopic and fellow eyes (Parisi, Scarale, Balducci, Fresina, & Campos, 2010; Teping, Kamps, & Reim, 1989) .
Defects in temporal processing in the human amblyopic visual system have also been described using psychophysical techniques (Altmann & Singer, 1986; Huang, Li, Deng, Yu, & Hess, 2012; Spang & Fahle, 2009; Steinman & Levi, 1988) . Studies in strabismic cats show V1 and extrastriate neurons driven by the amblyopic eye are sluggish, have impaired temporal structure, and have reduced population synchronization from the amblyopic eye (Crewther & Crewther, 1990; Eschweiler & Rauschecker, 1993; Roelfsema, König, Engel, Sireteanu, & Singer, 1994; Singer et al., 1980) . These temporal processing defects in cortical neurons could be a significant factor in the amblyopic deficit since Roelfsema, König, Engel, Sireteanu, and Singer (1994) found no significant differences in the spatial resolution and firing rate of cells driven by the amblyopic and fellow eye. Reduced synchronization is also expected to decrease activity from one cortical processing stage to the next because integration of desynchronized synaptic potentials will be less effective in generating excitatory post-synaptic potentials (Oviedo & Reyes, 2002; Stevens & Zador, 1998) . As a corollary in human amblyopia, recent studies in humans have shown increased latency variability in VEP epochs generated by the amblyopic eye compared to the fellow eye (Bankó, Körtvélyes, Németh, & Vidnyánszky, 2014; Bankó, Körtvélyes, Németh, Weiss, & Vidnyánszky, 2013) , possibly related to increased internal neural noise within the amblyopic visual system. Furthermore, Weiss and Kelly (2004) found that the VEP waveform has a sharper peak tuning after occlusion therapy suggesting occlusion therapy may reduce temporal variance or reduce internal noise in the amblyopic visual system.
To address the impact of reduced synchronization and temporal noise in visual cortex, we propose a theoretical model for the VEP generated by the amblyopic and fellow eyes (Fig. 1) . The simulated VEPs in the figure are characteristic of the VEPs generated by the amblyopic and fellow eye in children (Weiss & Kelly, 2004) . The fellow eye VEP response (A) is simulated by a sum of sinusoidal wavelet functions with constant relationships between amplitude, frequency, and phase. When the underlying components have accurate temporal synchronization of phase across a range of temporal frequencies, the VEP generates a waveform with sharply defined peaks of large amplitude. In contrast, the amblyopic response with reduced amplitude, mild latency delay, and broader peaks can be simulated by desynchronization of phase across the same range of temporal frequencies. Desynchronization could further lead to increased trial-to-trial latency variation in the amblyopic VEP (Bankó, Körtvélyes, Németh, & Vidnyánszky, 2014; Bankó, Körtvélyes, Németh, Weiss, & Vidnyánszky, 2013) . Alternatively, the abnormal VEP could arise from weak synaptic input in addition to random phase misalignments due to noise within the amblyopic visual system (Huang et al., 2012; Kiorpes, 2006; Levi, Klein, & Chen, 2008) .
In this study we examine phase-misalignment (or potential desynchronization) of underlying components and its impact on the VEP response in amblyopic children before and after occlusion therapy. Although the underlying components of the VEP are not known, Fourier analysis provides an objective framework to compare phase-alignment between the amblyopic and fellow eyes. First we determine if there is increased phase-misalignment (or noise) in the amblyopic visual system compared to the fellow eye. Second, we determine whether occlusion therapy alters phase-misalignment (or noise) in the VEP. Third, we address whether phase-misalignment can account for the VEP deficits relative to the fellow eye by comparing VEP parameters with or without correction for phase-misalignment in the VEP epochs.
Material and methods

Participants
This research adhered to the tenets of the Declaration of Helsinki and the institution's IRB granted permission to retrospectively review records. The data in this study provides a reanalysis of previous VEP recordings (Weiss & Kelly, 2004) . Ten amblyopic children (2-6 years old, mean = 4.1; s.d. = 1.4) underwent full ophthalmologic exam including acuity (Allen or Snellen optotypes), Titmus stereo testing if able, assessment of eye alignment, cycloplegic refraction, and dilated fundus examination. amblyopia was defined by the Amblyopia Treatment Study guidelines (PEDIG, 2002) as best-corrected interocular acuity difference P 0.3 log minimum angle of resolution (log MAR) related to strabismus and/or amblyogenic anisometropia with an otherwise normal eye examination. Amblyogenic anisometropic amblyopia was the presence of an interocular refractive difference of 0.50 diopters (D) or greater in spherical equivalent or a 1.5 D or greater difference in astigmatism in any meridian (meridional amblyopia). Strabismus was defined as any heterotropia at distance and/or near fixation of 10 prism diopters or more. Distance visual acuity was measured with appropriate optical correction determined by cycloplegic refraction. Optotypes were whole line Allen or Snellen targets, or isolated optotypes if the subject was uncooperative with whole line testing.
Occlusion therapy
All subjects were treated with full time monocular occlusion during waking hours, for treatment intervals of 1 week per year of age (this therapy was the standard of care at the time the data were collected). All testing was performed with subjects wearing their full optical correction. None of the subjects had their optical correction changed or had eye muscle surgery during therapy. Full time occlusion was repeated for up to three intervals or until the best acuity was achieved. Thereafter, part-time occlusion (4-6 h/ day for 4-7 days/week) was prescribed. Follow-up duration ranged from 0.3 to 9 years (mean = 4.1; s.d. = 2.5). Follow-up visual acuity assessments were performed at 1 week intervals per year of age to minimize the occurrence of reverse amblyopia. Reverse amblyopia, defined as a decrease of acuity in the occluded eye by 0.15 logMAR or greater, was not observed in this study.
VEP testing
Details of VEP recording, peak scoring, signal-to-noise ratio (SNR) calculations, and phase-misalignment correction have been previously described (Kelly, Darvas, & Weiss, 2014; Weiss & Kelly, 2004) and are briefly summarized here. Subject preparation for VEP recording followed International Society for Clinical Electrophysiology of Vision guidelines (Harding, Odom, Spileers, & Spekreijse, 1996) using Oz as active, Cz as reference and Pz as ground.VEP recordings were performed by a VENUS system (Neuroscientific Corp, Farmingdale, New York; no longer produced). The EEG was amplified 10,000 times, bandpass filtered 0.05-100 Hz, then digitized at 273.8 Hz. The VENUS system simultaneously generates calibrated 12-bit video at a 68.45 Hz frame rate, which was phase-locked to the EEG recording. Stimuli were presented on a monitor subtending 20 Â 20 degrees at 60 cm viewing distance. All stimuli were of saturating contrast (Kelly, Borchert, & Teller, 1997) to offset the reduced contrast sensitivity of the amblyopic visual system while having little effect on the control eye (Levi & Harwerth, 1978; Levi & Manny, 1982) . Stimuli were pattern-onset of sinewave gratings (99% contrast, 43 cd/m 2 mean luminance) of 0.5, 1, 2, and 4 cycles per degree (c/d) presented for 200 ms followed by a blank screen of the same mean luminance for 800 ms. Gratings were oriented horizontally and presented on large fields to minimize the impact of unsteady fixation and latent nystagmus artifact in the horizontal direction (Saunders, Brown, & McCulloch, 1997; Subramanian, Jost, & Birch, 2013; Zhang et al., 2008) . Additional stimuli consisted of contrast-reversing checkerboards (80% contrast, 1.4 Hz, 52 cd/m 2 mean luminance) of 163, 84, 42, and 18 arc minutes (results are provided in the Supplemental data). Subjects wore their optical correction and the untested eye was patched. Central fixation was maintained by a small toy ($1 degree visual angle) placed in the middle of the screen. Occlusion therapy was stopped at least 3 h before VEP testing to avoid short-tem occlusion effects (Tyler, Apkarian, Levi, & Nakayama, 1979) . Subjects had repeat VEP testing after occlusion therapy when visual acuity improved to 20/30 or better, or when visual acuity appeared to plateau (average 4 months; range 0.9-13.9 months).
Data processing and correction of phase-misalignment
Description of trial-by-trial latency variation in VEP epochs have been previously reported (Kremláček et al., 2012; Thornton, 2008) . For the purposes of this paper, we assume that phase-misalignment is the mechanism behind trial-by-trial latency variation. Details of artifact rejection, digital filtering, averaging, peak scoring, and automated latency correction of VEP epochs by phase alignment are previously described (Kelly, Darvas, & Weiss, 2014) . Data from pattern-onset and check reversal were analyzed at identical Fourier harmonic frequencies. The duration of the EEG epoch to be analyzed was the time from stimulus onset (or contrast-reversal) to 365.2 ms (set by the check reversal frequency of 2.738 Hz). Therefore, we only examined the initial onset portion of the pattern-onset stimulus. After each EEG epoch underwent a linear de-trend (starting and ending points were set to 0 lV), epochs were overlaid to aid in manual rejection of epochs with large artifacts. VEPs were then averaged without any further processing (''raw average'') or averaged following phase-alignment of epochs across multiple frequency components (''phasealigned''). The phase-aligned analysis uses a frequency bandwidth (5.5-21.9 Hz) that comprises most of the VEP signal. In controls, the phase-aligned method in the Fourier domain results in slightly larger amplitudes compared to alignment by cross correlation in the temporal domain (Kelly et al., 2014) . For phase-alignment, each epoch underwent Short-Term Fourier Transform after applying a Hamming window from 20 to 200 ms after stimulus onset. Each epoch was then represented as multiple points in a polar plot defined by distance from the origin (amplitude) and rotation (relative phase or timing) at each frequency (e.g., Victor & Mast, 1991) . When an averaged VEP is comprised of an underlying invariant response, all epochs have points that cluster tightly at each frequency and there is a systematic shift in phase and amplitude of these clusters with increasing frequency (Kelly et al., 2014) . (The phase shifts and amplitudes of the underlying components in Fig. 1A actually use values observed in control children.) From these clusters of points, an average and 95% confidence region (circle) was derived at each frequency. The SNR at each frequency was taken to be the magnitude divided by the radius of its 95% confidence circle (Zemon, Hartmann, Gordon, & Prunte-Glowazki, 1997) . The final SNR was defined as the sum of SNR greater than 1.3 across all frequencies. If none of the SNRs were greater than 1.3, the SNR was the largest of the relevant frequencies. The criteria for a determining the SNR and its sensitivity and specificity are detailed by Kelly et al. (2014) .
Correction of phase-misalignment consisted of shifting each epoch in time to match the average phase (for harmonics from 5.5 to 21.9 Hz) to that of the average template. Specifically, the analysis determines the phase shift at each frequency to match the template. We then convert phase shift to the equivalent latency shift (in time) at each temporal frequency. The average of latency shifts across temporal frequencies determines the amount each epoch is shifted in time. After the epochs were shifted in time (allowing for wrapping at the end points), the program recalculated the average phase template and reiterated phase shifts for each epoch until there was no further improvement in the SNR. Note that each frequency was weighted equally by phase error, not power, such that larger amplitude alpha, beta, or theta rhythms would not bias the calculation. The phase angle used to shift the epoch in time was limited at each corresponding frequency to be within ±52 ms.
After all averaging calculations (raw or phase-aligned), the averaged VEP response was digitally bandpass filtered from 1.4 to 40 Hz. The amplitude of the VEP peak (P100) was defined by the voltage difference between the dominant positive peak near 100 ms and the preceding N1 negative peak (or baseline if the N1 peak was absent). Latency was defined as the time from the stimulus onset to the dominant positive peak. Criteria for inclusion of N1 peak latency were (1) a negative going deflection after 40 ms and (2) a SNR ratio greater than 1.3. One author (JPK) scored the peaks of every waveform while masked to the subject's identity, age, and clinical status of the recorded eye. Statistical analysis was performed by EXCEL version 2003 (Microsoft Corp. Redmond WA) and SPSS version 12 (IBM, Armonk, New York) for repeated measures ANOVA. Table 1 summarizes the clinical findings. Of the 10 subjects, 4 subjects had isolated anisometropic amblyopia, 5 subjects had combined esotropic and anisometropic amblyopia, and 1 had isolated strabismic amblyopia. No subject had prior strabismus surgery. After occlusion therapy, mean visual acuity in the AE improved from 1.13 to 0.13 logMAR. All but one subject obtained 20/30 or better acuity in the amblyopic eye; the remaining subject failed to improve due to poor compliance with occlusion therapy. None of the subjects experienced reverse amblyopia. The average duration of occlusion therapy was 4 months (range 1-14 months). Age was not correlated with the number of accepted VEP epochs, P100 latency, P100 amplitude, or SNR (p > 0.18 for all). P100 peak amplitude was highly correlated with SNR (r = 0.73; p < 0.0001). LogMAR visual acuity was significantly correlated with SNR before and after occlusion therapy (r = 0.44; p = 0.008, r = 0.33; p = 0.04, respectively). LogMAR acuity was also correlated with P100 latency (r = 0.34; p = 0.045).
Results
Subject summary
Phase-misalignment
The amblyopic eye showed increased phase-misalignment compared to the fellow eye before occlusion therapy. Fig. 2 shows histograms of the latency shifts needed to align the epochs. Data from all spatial frequencies have been combined in this figure. Before occlusion therapy there is a small but significant difference between the variance in the amblyopic eye and that in the fellow eye (F-test; p < 0.0001; skew = À0.13 and À0.19 for the amblyopic and fellow eye, respectively). After occlusion therapy, the distribution of the variance in the amblyopic eye decreased while the variance in the fellow eye increased, such that both had similar distributions of variance (F-test; p = 0.83; skew = À0.26 and À0.11 for the amblyopic and fellow eye, respectively). Fig. 2C shows the standard deviation of latency shifts in the amblyopic and fellow eyes before and after occlusion therapy. Before occlusion therapy, the difference in phase-misalignment between the amblyopic and fellow eyes varied with spatial frequency (F-test; p = 0.20, 0.045, 0.0003, and p < 0.0001 for 0.5, 1, 2, and 4 c/d, respectively). After occlusion therapy, phase-misalignment in the amblyopic eye decreased similarly across all spatial frequencies. Phase-misalignment increased in the fellow eye predominately at 1 and 4 c/d.
Latency delay
Before occlusion therapy, the averaged response of the amblyopic eye demonstrated a small but significant latency delay (ANOVA; p = 0.042) across all spatial frequencies compared to the fellow eye (Fig. 3A) . After occlusion therapy, latency differences between the amblyopic and fellow eyes became insignificant (p = 0.11). Averaged across all spatial frequencies, amblyopic eyes showed a 5.4 ms decrease in latency while fellow eyes showed a 1.6 ms increase in latency relative to pre-occlusion (neither change was statistically significant). To test the hypothesis that phasemisalignment may explain the prolonged pre-therapy latency in the amblyopic eye compared to the fellow eye, we analyzed latency after epochs were corrected by phase-alignment. Fig. 3B shows the results before and after occlusion therapy. If phase-misalignment of the underlying components accounted for the prolonged VEP latency, then all lines would superimpose. However, even with phase-alignment, there continues to be a small but significant latency difference between the amblyopic and fellow eyes before occlusion therapy (ANOVA; p = 0.001). Only after occlusion therapy do the amblyopic and fellow eyes have nearly identical latencies (p = 0.56). Fig. 4A plots SNR after raw averaging before and after occlusion in both the amblyopic eye and fellow eye. The amblyopic eye has significantly lower SNR compared to the fellow eye before occlusion therapy (ANOVA, p = 0.007). Furthermore, the amblyopic eye has a disproportionate decrease in SNR with higher spatial frequency (ANOVA interaction p = 0.03). After occlusion therapy, the amblyopic eye shows improvement in SNR while the fellow eye shows a reduction in SNR such that inter-ocular differences are not statistically significant at any spatial frequency (ANOVA, p = 0.40; interaction, p = 0.59; comparison at each spatial frequency p P 0.34). For the amblyopic eye there was an overall 67% increase in SNR following occlusion therapy (p = 0.0004) that was not associated with spatial frequency (ANOVA interaction, p = 0.30). In comparison, the fellow eye showed a 22% decrease in SNR with occlusion therapy (p = 0.0003; ANOVA, interaction with spatial frequency, p = 0.28).
Signal-to-noise ratios
The SNR was significantly correlated with the standard deviation of latency shift needed to correct for phase-misalignment in the VEP epochs (collapsing across spatial frequency). For this analysis each eye's SNR ratio was correlated with the corresponding standard deviation of latency shift. For the amblyopic eye, a larger SNR was associated with a decrease in variability in phase-misalignment for both pre-occlusion (r = À0.73; p < 0.0001) and post-occlusion (r = À0.55; p = 0.0004). For the fellow eye, a larger SNR was also associated with a decrease in variability in phasemisalignment for both pre-occlusion (r = À0.68; p < 0.0001) and post-occlusion (r = À0.65; p < 0.0001).
To test the hypothesis that phase-misalignment may explain the reduced SNR in the amblyopic eye, we analyzed the SNR after epochs were corrected by phase-alignment (Fig. 4B) . If the reduced SNR in the amblyopic eye were fully explained by phase-misalignment of the underlying components, then SNR data for phasealigned responses from amblyopic and fellow eyes would be superimposable, both before and after therapy. After phase-alignment, there was no significant difference in SNR between the amblyopic and fellow eyes before therapy (ANOVA, p = 0.07; interaction, p = 0.80) or after therapy (ANOVA, p = 0.79; interaction, p = 0.25). Thus the data are consistent with phase-misalignment as a significant contributor to reduced SNR in the amblyopic VEP. Of note, phase-alignment improved SNR in the amblyopic eye before occlusion therapy by 2.5-5 fold. This improvement in SNR is larger than that seen in age matched controls (Kelly et al., 2014) . Phase-alignment improved SNR in the fellow eye 1.3-3.6 fold, which is within the range seen in age matched controls. The improvements in SNR with phase-alignments were less pronounced at high spatial frequencies. After therapy there were still small improvements in SNR with phase-alignment that were consistent with that seen in age matched controls.
VEP waveforms
Since phase-misalignment decreases with occlusion therapy, we also tested the hypothesis that the overall improvement in the VEP waveform after occlusion therapy might be explained by improved phase-alignment (Fig. 5) . If phase-misalignment accounts for the abnormal waveform in the amblyopic eye, then the waveforms before and after therapy should superimpose after correcting for phase-misalignment. At each spatial frequency, the grand average VEP represents an average of each subject's waveform after normalization to a maximum and minimum of 1.0 to À1.0. If the post-occlusion VEP improvements in the amblyopic eye were explained by phase-misalignment, both pre-and posttherapy waveforms in Fig. 5 would be identical after correction for phase-misalignment. At low spatial frequencies the waveforms are indeed similar pre-and post-therapy. However, at higher spatial frequencies, the waveform predicted on the basis of phasealignment substantially underestimates the response after occlusion therapy. Because phase-alignment eliminates significant differences in the SNR between the amblyopic and fellow responses (e.g., Fig. 4 ), the differences in VEP waveforms in Fig. 5 cannot be explained by phase-misalignment or noise, but rather by additional effects of occlusion therapy.
Strabismic versus anisometropic amblyopia
Subjects were divided into anisometropes without strabismus (subjects 1, 3, 5, and 8) versus those with strabismus (with or without anisometropia). Our data suggest that strabismic amblyopes tended to have more pronounced VEP abnormalities in SNR, amplitude, and phase-misalignment. Differences in VEP abnormalities between strabismic and anisometropic are shown in Table 2 for the pattern-onset stimulus. Only VEP SNR was statistically significant between the strabismic and anisometropic groups before occlusion therapy. After occlusion therapy, the amblyopic eye had nearly identical average SNR, latency, and VEP amplitudes between the strabismic and anisometropic groups.
Subjects with strabismus had larger variation in latency shifts in VEP epochs compared to the anisometropic group suggesting relatively greater phase-misalignment in strabismic amblyopia. Both the anisometropic and strabismic group showed a parallel decrease in variation after occlusion therapy (from pre-to posttherapy, strabismic s.d. changed from 25.4 to 23.7 ms, anisometropia s.d. changed from 23.1 to 22.1 ms), indicating occlusion therapy had similar effects in strabismic and anisometropic amblyopia. For both groups the fellow eye demonstrated increased variation in latency shifts after occlusion therapy (pre-to posttherapy: strabismic s.d. changed from 23.1 to 23.6 ms, anisometropia s.d. changed from 18.0 to 22.0 ms).
Results for checkerboard reversing stimuli
Results using checkerboard reversal stimuli generated similar outcomes to that seen in Figs. 2-5 (Supplemental Figs. 1-4) . Specifically, the amblyopic eyed showed increased phase-misalignment and latency prolongation compared to the fellow eye before occlusion therapy. Phase-alignment increased in the amblyopic eye, but decreased slightly in the fellow eye, after occlusion therapy. Latency was significantly longer in the amblyopic eye (p = 0.0001) which decreased after occlusion therapy to nearly equal the fellow eye (p = 0.09). However, correcting for phase-misalignment did not fully account for the pre-occlusion latency delay. Prior to occlusion therapy, the amblyopic eye had reduced SNR and VEP amplitude (p < 0.0005 for both) compared to the fellow eye. After occlusion therapy SNR and VEP amplitude were nearly equal between eyes (p > 0.07 for both). Correcting for phase-misalignment could account for pre-occlusion SNR reduction (Supplemental Fig. 3 ). VEP waveforms showed that phase-alignment before therapy substantially underestimated the waveform after occlusion therapy. Therefore, the pre-and post-therapy differences in VEP waveforms to checkerboard reversal stimuli cannot be completely explained by phase-misalignment or noise, but rather by additional effects of occlusion therapy.
Early conduction velocity
Finally, early conduction velocity, reflected in the N1 latency, was compared between amblyopic and fellow eyes. The analysis used the 4 c/d gratings and 84 arc minute check stimuli since only these stimuli reliably generated N1 peaks according to our criteria. N1 latency from the amblyopic eye was not significantly prolonged compared to the fellow eye either before occlusion therapy (amblyopic eye = 105.5 ms vs. fellow eye = 85.6 ms; p = 0.13) or after occlusion therapy (amblyopic eye = 84.4 ms vs. fellow eye = 89.1 ms; p = 0.59). Similar results were found for 84 arc minute checks. However, the few outliers with long N1 latencies were amblyopic eyes with very low SNR and thus have latencies that were suspect due to low signal.
Discussion
This study shows increased phase-misalignment, low SNR, and waveform reductions in the VEP generated by the amblyopic eye compared to the fellow eye in children with amblyopia. Occlusion therapy increases phase-alignment and improves SNR in the amblyopic eye. The data are consistent with previous studies showing desynchronization and increased temporal noise in the cortical response from the amblyopic eye (Bankó et al., 2014; Roelfsema et al., 1994; Singer et al., 1980) . While phase-misalignment does not explain all aspects of the amblyopic VEP waveform, improvement in phase-alignment with occlusion therapy may contribute to overall improvement in the VEP waveform after treatment. Correcting for phase-misalignment using our methods could not fully account for the abnormally long latency in the amblyopic eye or the reduced VEP response to stimuli at higher spatial frequencies before occlusion therapy. Correcting phasealignment could not explain the improved VEP response at higher spatial frequencies after occlusion therapy. Therefore, the effects of occlusion therapy on VEP responses are greater than that accounted for by improvements in phase-alignment and SNR alone.
The increased phase-alignment and improvement in SNR after occlusion therapy could arise from a stronger signal and/or reduction in noise from the amblyopic eye. Previous studies have demonstrated that VEP amplitude from the amblyopic eye significantly increases after occlusion therapy. Because the early VEP peaks likely arise from excitatory post-synaptic potentials in striate and extrastriate cortex (Di Russo et al., 2005; Mitzdorf & Singer, 1978; Nunez & Srinivasan, 2006 ) the improvement in VEP response after occlusion therapy indicates strengthening of synaptic connections, or increasing the number of active synapses from the amblyopic eye. In addition, our data suggest occlusion therapy likely improves synchronization across the cortical areas generating the VEP. After occlusion therapy, we propose the amblyopic eye primarily strengthens its synaptic input (Antonini, Gillespie, Crair, & Stryker, 1998; Blakemore, Garey, & Vital-Durand, 1978) , which in turn increases the signal relative to the noise and subsequently improves synchronization (phase alignment) by mass summation in the ensemble of V1 and extrastriate cortical cells.
Fixation stability
Another explanation for an increase in phase-alignment with occlusion therapy could be improvements in fixation stability in the amblyopic eye (Gonzalez, Wong, Niechwiej-Szwedo, TaritaNistor, & Steinbach, 2012) . However, horizontal gratings are expected to minimize the impact of unsteady fixation, which in amblyopes tends to be larger in the horizontal direction (Subramanian, Jost, & Birch, 2013) . Instead, our findings were similar whether using horizontal gratings or checkerboard reversal stimuli in which responses are very sensitive to horizontal fixation instability (Saunders et al., 1997) . Furthermore, improvements in fixation are unlikely to explain the slight increases in phase-alignment of the fellow eye with occlusion therapy. Simultaneous eye movement and VEP recordings in amblyopic children would be needed to further address the potential role of fixation stability with respect to VEP phase-alignment.
Effects on the fellow eye
Reverse amblyopia (loss of acuity in the fellow eye) was not observed in this study despite full-time occlusion. Our low incidence of reverse amblyopia is consistent with other studies using a larger cohort of subjects (Foley-Nolan, McCann & O'Keefe, 1997; Jin, Chow, Colpa, & Wong, 2013; PEDIG, 2008) . Furthermore, visual acuity in the fellow eye was not affected despite significant reductions in SNR and increased phase-misalignment after occlusion therapy, suggesting there are functional changes in cortical activation from the patched eye, which are not reflected by visual acuity. The reduced SNR in the fellow eye after patching is likely due to increased phase-misalignment since the two measures are significantly correlated. Other factors such as patching compliance across subjects and duration between patching and VEP testing may play a role. Further studies would be required to assess whether the changes observed in the fellow eye following occlusion therapy represent transient or long-term changes.
In conclusion, apparent temporal desynchronization (phase misalignment) of the amblyopic eye VEP response contributes to a low SNR and improves with occlusion therapy. However, changes in phase misalignment alone cannot account for all the improvements seen in the amblyopic eye VEP waveform after occlusion therapy.
